Assessment of myocardial adrenergic innervation with a solid-state dedicated cardiac cadmium-zinc-telluride camera: First clinical experience

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 5, 2014, Pages 575-585

  Gimelli, Alessia ^a   Liga, Riccardo ^b   Giorgetti, Assuero ^a   Genovesi, Dario ^a   Marzullo, Paolo ^a,c  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Cardiac innervation; CZT camera; Heart to mediastinum ratio

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CADMIUM; TELLURIDE; TELLURIUM DERIVATIVE; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG; ZINC; (3 IODOBENZYL)GUANIDINE; CDZNTE; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; TELLURIUM;

ADRENERGIC NERVE; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; FEMALE; GAMMA CAMERA; HEART EJECTION FRACTION; HEART INNERVATION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MALE; MYOCARDIAL ADRENERGIC INNERVATION; PRIORITY JOURNAL; SOLID STATE; SYMPATHETIC INNERVATION; ADRENERGIC NERVE CELL; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; HEART; HEART MUSCLE ISCHEMIA; INNERVATION; MIDDLE AGED; PROCEDURES; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; ADRENERGIC NEURONS; AGED; CADMIUM; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOPHARMACEUTICALS; TELLURIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; ZINC;

EID: 84898871775     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jet258     Document Type: Article

References (29)

1. Carrio? I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with MIBG in heart failure. JACC Cardiovasc Imaging 2010;3:92-100.
2. Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomie nerve activity in normal subjects. J Nucl Med 1997;38:49-52.
3. Kasama S, Toyama T, Sumino H, Nakazawa M, Matsumoto N, Sato Y et al. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction. J Nucl Med 2008;49:907-14.
4. Jacobson AF, Senior R, Cerqueira MD,Wong ND, Thomas GS, Lopez VA et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. J Am Coll Cardiol 2010;55:2212-21.
5. Nishisato K, Hashimoto A, NakataT, DoiT,Yamamoto H, NagaharaDet al. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: Quantification of cardiac tracers in patients with ICDs. J Nucl Med 2010; 51:1241-9.
6. Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 2001;42:1757-67.
7. Chen J, Folks RD, Verdes L, Manatunga DN, Jacobson AF, Garcia EV. Quantitative I-123MIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake. J Nucl Cardiol 2012;19:92-9.
8. Veltman CE, Boogers MJ, Meinardi JE, Al Younis I, Dibbets-Schneider P, Van der Wall EE et al. Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012;39:1599-608.
9. Marini C, Giorgetti A, Gimelli A, Kusch A, Sereni N, L'abbate A et al. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2005;32:682-8.
10. Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parzek P, AgostiniDet al. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing. Circ Cardiovasc Imaging 2008;1:131-40.
11. Boogers MJ, Borleffs CJ, Henneman MH, vanBommel RJ, van Ramshorst J, Boersma E et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverterdefibrillator patients. J Am Coll Cardiol 2010;55:2769-77.
12. Esteves FP, Raggi P, Folks RD, Keidar Z, Askew JW, Rispler S et al. Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: Multicenter comparison with standard dual detector cameras. J Nucl Cardiol. 2009;16:927-34.
13. Gimelli A, Bottai M, Giorgetti A, Genovesi D, Kusch A, Ripoli A et al. Comparison between ultrafast and standard single-photon emission CTin patients with coronary artery disease: A pilot study. Circ Cardiovasc Imaging 2011;4:51-8.
14. Kochiadakis G, Marketou M, Koukouraki S, Parthenakis F, Chlouverakis G, Karkavitsas N et al. Cardiac autonomic disturbances in patients with vasovagal syndrome: Comparison between iodine-123-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability. Europace 2012;14:1352-8.
15. Herzog BA, Buechel RR, Katz R, Brueckner M, Husmann L, Burger IA et al. Nuclear myocardial perfusion imaging with a cadmium-zinc-telluride detector technique: Optimized protocol for scan time reduction. J Nucl Med 2010;51:46-51.
16. Highley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV et al. Technetium 99m-1,2-bis(bis(2-ethoxyethyl)phosphino)ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion agent. J Nucl Med 1993;34: 30-8.
17. Flotats A, Carrio? I, Agostini D, Le Guludec D, Marcassa C, Scha?fersMet al. Proposal for standardization of 123 I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802-12.
18. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: The second generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005;46:1023-7.
19. Lipke CS, Kuhl HP, Nowak B, Kaiser HJ, Reinartz P, Koch KC et al. Validation of 4D-MSPECT and QGS for quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPET: Comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2004;31:482-90.
20. Patel D, Robinson VJ, Arteaga RB, Thornton JW. Diastolic filling parameters derived from myocardial perfusion imaging can predict left ventricular end-diastolic pressure at subsequent cardiac catheterization. J Nucl Med 2008;49:746-51.
21. Lin GS, Hines HH, Grant G, Taylor K, Ryals C. Automated quantification of myocardial ischemia and wall motion defects by use of cardiac SPECT polar mapping and 4-dimensional surface rendering. J Nucl Med Technol 2006;34:3-17.
22. Sharir T, BermanDS,Waechter PB, Areeda J, Kavanagh PB,Gerlach J et al.Quantitative analysisof regionalmotionandthickeningby gatedmyocardialperfusionSPECT:normal heterogeneity and criteria for abnormality. J NuclMed 2001;42:1630-8.
23. Shah AM, Bourgoun M, Narula J, Jacobson AF, Solomon SD. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123-MIBG in heart failure. J Am Coll Cardiol Imaging 2012;5:1139-46.
24. Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y et al. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. Eur Heart J 2007;28: 989-95.
25. Sakata K, Mochizuki M, Yoshida H, Nawada R, Ohbayashi K, Ishikawa J et al. Cardiac sympathetic dysfunction contributes to left ventricular remodeling after acute myocardial infarction. Eur J Nucl Med 2000;27:1641-9.
26. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Musha H, Sasaka K. 123I-MIBG myocardial scintigraphy in patients with 'Takotsubo' cardiomyopathy. J Nucl Med 2004; 45:1121-7.
27. Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G et al. Extent of cardiac sympathetic imaging is determined by the area of ischemia in patients with acute coronary syndrome. Circulation 2000;101:2579-85.
28. Zhao C, Shuke N, YamamotoW, Okizaki A, Sato J, Ishikawa Y et al. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by 123I-MIBG SPECTand 99mTc-tetrofosmin electrocardiographically gated SPECT. J Nucl Med 2001;42:1017-24.
29. Estorch M, Narula J, Flotats A, Mari? C, Tembl A, Marti?n JC et al. Concordance between rest MIBG and exercise tetrofosmin defects: Possible use of rest MIBG imaging as a marker of reversible ischaemia. Eur J Nucl Med 2001;28:614-9.